Sun Pharma on Monday said it has elevated Aalok Shanghvi as Chief Operating Officer.

He is currently designated as Whole-time Director and Executive Vice-President, Emerging Markets, Global Generic R&D, Global Business Development (Generics), Operations and API.

Shanghvi, son of Sun Pharma MD Dilip Shanghvi, joined Sun Pharma in 2006 and has handled various roles in marketing, R&D, project management, purchase and communications, the Mumbai-based drug major said in a regulatory filing.